Upexi Inc (UPXI)

NASDAQCommunication ServicesInternet Content & InformationSnapshot 2026-10-23

$0.77-4.40%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Upexi Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	5.6M
EPS	—	-0.19
Annual ending 2027-06-30
Revenue	—	26.7M
EPS	—	-0.11
Annual ending 2028-06-30
Revenue	—	43.6M
EPS	—	0.02

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Reduce net losses from -$109M	A supporting condition in Upexi Inc's published investment case. The stated target is Net loss less negative than -$109 million.	Broken	Net loss worsens beyond -$109 million	Net income: $-24.544M FY2026-Q4; GAAP. Published target: Net loss less negative than -$109 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Source published Sep 17, 2026-24,544,060 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q4 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q4. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 quarters including 2026-Q1 and 2026-Q3. Management reduced operational costs including workforce and facility expenses, aiming for staking revenue to exceed cash expenses by July 1, 2026. Gross profit improved significantly from $1.56M in 2025-Q3 to $4.35M in 2026-Q3, but operating income remains deeply negative at -$106.8M in 2026-Q3 due to unrealized digital asset losses. The trajectory shows partial delivery on cost reduction but ongoing challenges in profitability. Delivery assessment Oct 24, 2026
Reduce negative cash from operations below -$4.8M	Cash from operations improved from -$9.8M to -$4.8M in recent quarters.	Broken	Cash from operations falls below -$4.8 million	Cash from operations: $-3.718M FY2026-Q4; GAAP. Published target: Cash from operations better than -$4.8 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Source published Sep 17, 2026-3,717,677 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q4 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q4. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 quarters including 2026-Q1 and 2026-Q3. Management reduced operational costs including workforce and facility expenses, aiming for staking revenue to exceed cash expenses by July 1, 2026. Gross profit improved significantly from $1.56M in 2025-Q3 to $4.35M in 2026-Q3, but operating income remains deeply negative at -$106.8M in 2026-Q3 due to unrealized digital asset losses. The trajectory shows partial delivery on cost reduction but ongoing challenges in profitability. Delivery assessment Oct 24, 2026
Manage $36 million convertible promissory note	Upexi aims to manage $36M in convertible notes to support operations.	Improving	Convertible note management fails or debt burden increases materially	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve revenue growth near 29% next year	Revenue is expected to grow about 29% next year.	Recovered	Revenue growth falls below 20% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-06-30 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-10	Unavailable	Unavailable	0 / 1
2026-09-11	Unavailable	Unavailable	1 / 1
2026-09-12	Unavailable	Unavailable	1 / 1
2026-09-13	Unavailable	Unavailable	1 / 1
2026-09-14	Unavailable	Unavailable	1 / 1
2026-09-15	Unavailable	Unavailable	1 / 1
2026-09-16	Unavailable	Unavailable	1 / 1
2026-09-17	Unavailable	Unavailable	1 / 1
2026-09-18	Unavailable	Unavailable	1 / 1
2026-09-19	Unavailable	Unavailable	1 / 1
2026-09-20	Unavailable	Unavailable	1 / 1
2026-09-21	Unavailable	Unavailable	1 / 1
2026-09-22	Unavailable	Unavailable	1 / 1
2026-09-23	Unavailable	Unavailable	1 / 1
2026-09-24	Unavailable	Unavailable	1 / 1
2026-09-25	Unavailable	Unavailable	1 / 1
2026-09-26	Unavailable	Unavailable	1 / 1
2026-09-27	Unavailable	Unavailable	1 / 1
2026-09-28	Unavailable	Unavailable	1 / 1
2026-09-29	Unavailable	Unavailable	1 / 1
2026-09-30	Unavailable	Unavailable	1 / 1
2026-10-01	Unavailable	Unavailable	1 / 1
2026-10-02	Unavailable	Unavailable	1 / 1
2026-10-03	Unavailable	Unavailable	1 / 1
2026-10-04	Unavailable	Unavailable	1 / 1
2026-10-05	Unavailable	Unavailable	1 / 1
2026-10-06	Unavailable	Unavailable	1 / 1
2026-10-07	Unavailable	Unavailable	1 / 1
2026-10-08	Unavailable	Unavailable	1 / 1
2026-10-09	Unavailable	Unavailable	1 / 1
2026-10-10	Unavailable	Unavailable	1 / 1
2026-10-11	Unavailable	Unavailable	1 / 1
2026-10-12	Unavailable	Unavailable	1 / 1
2026-10-13	Unavailable	Unavailable	1 / 1
2026-10-14	Unavailable	Unavailable	1 / 1
2026-10-15	Unavailable	Unavailable	1 / 1
2026-10-16	Unavailable	Unavailable	1 / 1
2026-10-17	Unavailable	Unavailable	1 / 1
2026-10-18	Unavailable	Unavailable	1 / 1
2026-10-19	Unavailable	Unavailable	1 / 1
2026-10-20	Unavailable	Unavailable	1 / 1
2026-10-21	Unavailable	Unavailable	1 / 1
2026-10-22	Unavailable	Unavailable	1 / 1
2026-10-23	Unavailable	Unavailable	1 / 1
2026-10-24	Unavailable	Unavailable	1 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	2	0	0
2026-06-01	2	0	0
2026-07-01	2	0	0
2026-08-01	2	0	0
2026-09-01	1	0	0
2026-10-01	1	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Reduce net losses from -$109MPublished status: Broken
Reduce negative cash from operations below -$4.8MPublished status: Broken
Manage $36 million convertible promissory noteDirect metric needs a verified mapping
Achieve revenue growth near 29% next yearDirect metric needs a verified mapping

Next proof point

Nov 10, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

4.1%Typical daily move · historical

Downside history

-88.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Upexi Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a high-risk, loss-making business with a speculative growth profile, not a proven durable compounder. The long-term thesis is in a watch state: momentum measures improved, but recent financial performance remains weak relative to its industry cohort.

What's priced into Upexi Inc

UPXI is valued at a substantial premium to peers despite weak execution and loss-making fundamentals, and the evidence flags that premium as unjustified. The expectations gap is elevated, while confidence in the valuation model is low, so what the market assumes is difficult to pin down precisely.

What the fundamentals likely do

Near-term results remain at risk: the company has missed in recent quarters, and the evidence puts the chance of another miss at 51%. Gross profit improved by 2026-Q3 and management has cut some costs, but operating income remained deeply negative, largely due to unrealized digital asset losses. Management is also raising and managing capital, while the Solana treasury strategy and the goal of improving cash flow remain works in progress.

What Upexi Inc hinges on

Over the next few quarters, the thesis hinges on whether cost control and staking revenue can improve cash flow without further weak execution or a guidance cut. A rate-cutting cycle or continued earnings strength from major Communication Services companies could support the sector backdrop, but would not resolve UPXI’s company-specific profitability challenges.